Finance

Lists
ZYDUSWELL:NSE
Zydus Wellness Ltd
515,00 INR
+0,99%
(+5,05) 1D
16-окт., 15:30:01 GMT+5:30  ·   INR
All symbols
SymbolPriceChange% Change
Generating top insights for ZYDUSWELL...
Open
512,85 INR
High
515,00 INR
Low
506,30 INR
Mkt. cap
163,85 млд
Avg. vol.
427,71 миң
Volume
52,40 миң
Dividend
0,23%
Quarterly dividend
0,30 INR
Ex-dividend date
2026-ж., 17-июл.
P/E ratio
87,70
52-wk high
611,85 INR
52-wk low
367,55 INR
EPS
5,87 INR
Shares outstanding
39,07 млн
No. of employees
2 миң
Open
512,85 INR
High
515,00 INR
Low
506,30 INR
Mkt. cap
163,85 млд
Avg. vol.
427,71 миң
Volume
52,40 миң
Dividend
0,23%
Quarterly dividend
0,30 INR
Ex-dividend date
2026-ж., 17-июл.
P/E ratio
87,70
52-wk high
611,85 INR
52-wk low
367,55 INR
EPS
5,87 INR
Shares outstanding
39,07 млн
No. of employees
2 миң
News stories
From web sources and news partners
Profile
Zydus Wellness is an Indian consumer goods company, which produces nutrition and skincare products. Headquartered in Ahmedabad, it is a subsidiary of the pharmaceutical company Zydus Lifesciences. Its brands include Glucon-D, Sugar Free, EverYuth, Complan, and Nycil. As of 2021, the company operates three manufacturing plants, one in Gujarat and two in Sikkim. Wikipedia
About Zydus Wellness Ltd
CEOTarun G. Arora
Employees1,68 миң
Founded1994
Headquarters-
Sector-
Last report
2026-ж., 4-авг.
Fiscal period
Q1 2027
3,74 INR / 3,93 INR
-4,92%miss
Revenue / Est. (INR)
14,37 млд / 14,66 млд
-1,96%miss
Fiscal Q1 2027 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in INR
Loading Previous Earnings...
Revenue
Net income
All values in INR
2025-ж. сен.
2025-ж. дек.
2026-ж. мар.
2026-ж. июн.
Revenue
6,50 млд
9,65 млд
14,85 млд
14,37 млд
Cost of goods sold
3,06 млд
3,53 млд
5,43 млд
4,93 млд
Cost of revenue
3,06 млд
3,53 млд
5,43 млд
4,93 млд
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1,60 млд
2,53 млд
4,47 млд
3,58 млд
Operating expense
3,48 млд
6,07 млд
7,32 млд
7,59 млд
Total operating expenses
6,54 млд
9,60 млд
12,75 млд
12,52 млд
Operating income
-37,00 млн
48,00 млн
2,10 млд
1,85 млд
Other non operating income
14,00 млн
8,00 млн
-71,00 млн
38,00 млн
EBT including unusual items
-506,00 млн
-415,00 млн
1,77 млд
1,62 млд
EBT excluding unusual items
-164,00 млн
-349,00 млн
1,74 млд
1,62 млд
Income tax expense
22,00 млн
-16,00 млн
153,00 млн
432,00 млн
Effective tax rate
-4,35%
3,86%
8,63%
26,65%
Other operating expenses
1,63 млд
2,99 млд
2,29 млд
3,44 млд
Net income
-528,00 млн
-399,00 млн
1,62 млд
1,19 млд
Net profit margin
-8,12%
-4,14%
10,91%
8,27%
Earnings per share
-0,58
-1,06
5,09
3,74
Interest and investment income
-
-
14,00 млн
-
Interest expense
-157,00 млн
-412,00 млн
-356,00 млн
-263,00 млн
Net interest expenses
-157,00 млн
-412,00 млн
-342,00 млн
-263,00 млн
Depreciation and amortization charges
251,00 млн
555,00 млн
553,00 млн
571,00 млн
EBITDA
142,50 млн
112,50 млн
2,46 млд
2,20 млд
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
Google колдонмолору